Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) (BIO_ALS-01)

This study has been completed.
Sponsor:
Collaborators:
ALS Association
ALS Therapy Alliance
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
James D. Berry MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00677768
First received: May 9, 2008
Last updated: June 2, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)